Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bilateral SERS-Microneedle Patch for Co-Diagnosis of Diabetes Mellitus and Tuberculosis Comorbidity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Disrupting KAT8 Liquid-Liquid Phase Separation with Hybrid Vesicle-Liposome Platform for Enhanced PD-L1 Blockade Treatment.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Single-cell multiomics uncovers an endothelial mechanosensitive PIEZO1-IL-33 axis driving pulmonary fibrosis.

Nature communications·2026
Same author

"AND" Logic-Gated Biomimetic Nanoparticles to Activate Macrophage Phagocytosis for Cancer Immunotherapy.

Nano letters·2026
Same author

A Programmable Nanoreactor Orchestrates Cascade of DNA Sensing to Amplify cGAS-STING Activation for Cancer Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

相关实验视频

Updated: Jul 3, 2025

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

2.6K

为癌症免疫治疗而设计的生物基水凝.

Yuxuan Peng1,2, Shuang Liang1,2, Qian-Fang Meng3

  • 1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.

Advanced materials (Deerfield Beach, Fla.)
|February 16, 2024
PubMed
概括

生物基水凝为癌症免疫疗法提供了一个有希望的平台,增强免疫反应并减少副作用. 本综述探讨了它们的应用和临床转化潜力.

关键词:
生物基水凝是一种生物基水凝.癌症治疗 治疗 治疗 癌症免疫激活系统的激活免疫疗法 免疫疗法局部化管理局部化管理

更多相关视频

Author Spotlight: In Vitro Hydrogel Model for Glioblastoma Microenvironment Study
10:44

Author Spotlight: In Vitro Hydrogel Model for Glioblastoma Microenvironment Study

Published on: September 22, 2023

1.4K
Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation
16:20

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation

Published on: July 2, 2018

18.6K

相关实验视频

Last Updated: Jul 3, 2025

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

2.6K
Author Spotlight: In Vitro Hydrogel Model for Glioblastoma Microenvironment Study
10:44

Author Spotlight: In Vitro Hydrogel Model for Glioblastoma Microenvironment Study

Published on: September 22, 2023

1.4K
Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation
16:20

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation

Published on: July 2, 2018

18.6K

科学领域:

  • 生物医学工程 生物医学工程
  • 材料科学 材料科学 材料科学
  • 免疫学 免疫学 免疫学

背景情况:

  • 免疫疗法正在彻底改变癌症治疗,但面临的挑战包括效率有限和副作用,特别是在固体瘤中.
  • 水凝是用于控制药物和细胞输送的多功能生物材料.
  • 免疫调节水凝可以增强抗癌免疫反应,并通过局部传递减少全身毒性.

研究的目的:

  • 审查用于癌症免疫治疗的生物基水凝的最新进展.
  • 突出利用这些水凝的协同组合方法.
  • 引导水凝的合理设计,以改善癌症免疫治疗结果.

主要方法:

  • 关于癌症免疫治疗中的生物基水凝的最新科学文献的综述.
  • 应用程序和协同战略的分析.
  • 讨论水凝的特性,包括生物相容性和受控释放.

主要成果:

  • 生物基水凝由于其生物相容性和可调性特性,在癌症免疫治疗中显示出显著的潜力.
  • 封装和在水凝内局部输送可以提高治疗效果并减少与免疫相关的副作用.
  • 水凝与其他治疗方式的协同组合有望改善治疗结果.

结论:

  • 生物基水凝是促进癌症免疫治疗的有希望的平台.
  • 进一步的研究和合理的设计对于临床翻译至关重要.
  • 这些材料为更有效,更安全的癌症治疗提供了途径.